Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intellectual Disability | 6 | 2023 | 1061 | 0.920 |
Why?
|
| Pain Management | 1 | 2024 | 182 | 0.810 |
Why?
|
| Chronic Pain | 1 | 2024 | 129 | 0.800 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 2022 | 46 | 0.760 |
Why?
|
| Precision Medicine | 1 | 2024 | 317 | 0.740 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 242 | 0.730 |
Why?
|
| Collagen Type I | 1 | 2019 | 112 | 0.650 |
Why?
|
| Hearing Loss | 2 | 2019 | 132 | 0.640 |
Why?
|
| Mutation | 6 | 2024 | 5815 | 0.610 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2019 | 150 | 0.570 |
Why?
|
| Phenotype | 8 | 2024 | 4260 | 0.550 |
Why?
|
| Collagen Type II | 1 | 2016 | 24 | 0.540 |
Why?
|
| Hip Joint | 1 | 2016 | 38 | 0.540 |
Why?
|
| Osteochondrodysplasias | 1 | 2016 | 68 | 0.520 |
Why?
|
| Genetic Association Studies | 2 | 2016 | 777 | 0.520 |
Why?
|
| Tibial Fractures | 1 | 2016 | 59 | 0.510 |
Why?
|
| Growth Disorders | 1 | 2016 | 210 | 0.480 |
Why?
|
| Developmental Disabilities | 2 | 2018 | 709 | 0.460 |
Why?
|
| Plasmapheresis | 1 | 2011 | 29 | 0.370 |
Why?
|
| Haploinsufficiency | 3 | 2022 | 257 | 0.370 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2011 | 35 | 0.370 |
Why?
|
| Microcephaly | 2 | 2024 | 332 | 0.360 |
Why?
|
| Transcription Factors | 3 | 2018 | 2609 | 0.330 |
Why?
|
| Peritoneal Dialysis | 1 | 2011 | 119 | 0.320 |
Why?
|
| Blood Transfusion | 1 | 2011 | 309 | 0.320 |
Why?
|
| DNA-Binding Proteins | 4 | 2020 | 2060 | 0.300 |
Why?
|
| Cardiomyopathies | 1 | 2011 | 489 | 0.260 |
Why?
|
| Genotype | 4 | 2022 | 2557 | 0.250 |
Why?
|
| Glutarates | 1 | 2024 | 37 | 0.240 |
Why?
|
| CADASIL | 1 | 2024 | 8 | 0.240 |
Why?
|
| Arginine-tRNA Ligase | 1 | 2024 | 9 | 0.230 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2020 | 506 | 0.230 |
Why?
|
| Mutation, Missense | 3 | 2019 | 869 | 0.220 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2023 | 27 | 0.220 |
Why?
|
| Syndrome | 4 | 2020 | 1118 | 0.220 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 66 | 0.220 |
Why?
|
| Acidosis, Lactic | 1 | 2023 | 30 | 0.210 |
Why?
|
| MELAS Syndrome | 1 | 2023 | 33 | 0.210 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2024 | 114 | 0.210 |
Why?
|
| Goldenhar Syndrome | 1 | 2023 | 13 | 0.210 |
Why?
|
| Child, Preschool | 8 | 2024 | 14054 | 0.200 |
Why?
|
| Collagen Type V | 1 | 2022 | 4 | 0.200 |
Why?
|
| Mitochondrial Diseases | 1 | 2024 | 135 | 0.200 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2022 | 30 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 374 | 0.190 |
Why?
|
| Metabolomics | 1 | 2024 | 419 | 0.180 |
Why?
|
| Micrognathism | 2 | 2018 | 66 | 0.180 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 5 | 1 | 2021 | 4 | 0.180 |
Why?
|
| Hand Deformities, Congenital | 2 | 2018 | 89 | 0.180 |
Why?
|
| Collagen | 1 | 2022 | 316 | 0.180 |
Why?
|
| Neck | 2 | 2018 | 137 | 0.180 |
Why?
|
| Brain Diseases | 1 | 2023 | 300 | 0.170 |
Why?
|
| Face | 2 | 2018 | 180 | 0.170 |
Why?
|
| SOXD Transcription Factors | 1 | 2019 | 4 | 0.170 |
Why?
|
| Fibroblasts | 1 | 2024 | 891 | 0.160 |
Why?
|
| Humans | 20 | 2024 | 124809 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 459 | 0.160 |
Why?
|
| North America | 1 | 2019 | 239 | 0.160 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 313 | 0.160 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 1894 | 0.150 |
Why?
|
| Child | 8 | 2024 | 24462 | 0.140 |
Why?
|
| Chromosome Deletion | 1 | 2021 | 647 | 0.140 |
Why?
|
| Exome | 3 | 2016 | 1042 | 0.140 |
Why?
|
| Male | 11 | 2024 | 61306 | 0.140 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2016 | 11 | 0.130 |
Why?
|
| Galactosyltransferases | 1 | 2016 | 6 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 537 | 0.130 |
Why?
|
| Bone Diseases, Developmental | 1 | 2016 | 58 | 0.130 |
Why?
|
| Histones | 1 | 2020 | 534 | 0.130 |
Why?
|
| Autoantigens | 1 | 2016 | 119 | 0.130 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2021 | 401 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 120 | 0.130 |
Why?
|
| Stroke | 1 | 2023 | 984 | 0.120 |
Why?
|
| Behcet Syndrome | 1 | 2015 | 17 | 0.120 |
Why?
|
| Adenosine Triphosphate | 1 | 2016 | 284 | 0.120 |
Why?
|
| Eye Abnormalities | 1 | 2016 | 106 | 0.120 |
Why?
|
| Abnormalities, Multiple | 2 | 2018 | 963 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 2016 | 393 | 0.120 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2015 | 48 | 0.120 |
Why?
|
| Alleles | 2 | 2016 | 1619 | 0.120 |
Why?
|
| Pedigree | 3 | 2024 | 1595 | 0.120 |
Why?
|
| Female | 10 | 2024 | 66575 | 0.120 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2016 | 871 | 0.120 |
Why?
|
| Radiography | 1 | 2016 | 828 | 0.110 |
Why?
|
| Adolescent | 4 | 2019 | 19331 | 0.110 |
Why?
|
| Neurons | 1 | 2024 | 1962 | 0.110 |
Why?
|
| Infant | 4 | 2024 | 12488 | 0.100 |
Why?
|
| Mice | 4 | 2023 | 17743 | 0.100 |
Why?
|
| Muscle Hypotonia | 2 | 2024 | 188 | 0.100 |
Why?
|
| Heart Auscultation | 1 | 2011 | 7 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2022 | 4355 | 0.090 |
Why?
|
| Animals | 5 | 2023 | 34188 | 0.080 |
Why?
|
| Young Adult | 2 | 2019 | 8991 | 0.080 |
Why?
|
| Adult | 3 | 2024 | 29482 | 0.060 |
Why?
|
| Echocardiography | 1 | 2011 | 1052 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2011 | 974 | 0.060 |
Why?
|
| Leukemia, Megakaryoblastic, Acute | 1 | 2005 | 20 | 0.060 |
Why?
|
| Neoplasms | 1 | 2020 | 2789 | 0.060 |
Why?
|
| Disease Progression | 1 | 2011 | 2052 | 0.060 |
Why?
|
| Receptor, Notch3 | 1 | 2024 | 12 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2005 | 137 | 0.060 |
Why?
|
| Centrioles | 1 | 2023 | 13 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2011 | 634 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2023 | 22 | 0.060 |
Why?
|
| Facial Asymmetry | 1 | 2023 | 18 | 0.050 |
Why?
|
| Citrulline | 1 | 2023 | 107 | 0.050 |
Why?
|
| Glutathione | 1 | 2023 | 193 | 0.050 |
Why?
|
| Ion Channels | 1 | 2023 | 194 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5155 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2005 | 809 | 0.050 |
Why?
|
| Arginine | 1 | 2023 | 331 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2023 | 615 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 366 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 376 | 0.040 |
Why?
|
| Middle Aged | 1 | 2019 | 26727 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2024 | 8189 | 0.040 |
Why?
|
| Brain | 2 | 2023 | 3010 | 0.040 |
Why?
|
| Acetylation | 1 | 2020 | 175 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 137 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 3143 | 0.040 |
Why?
|
| Multiprotein Complexes | 1 | 2020 | 207 | 0.040 |
Why?
|
| Seizures | 1 | 2024 | 879 | 0.040 |
Why?
|
| Proteins | 1 | 2023 | 1045 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 296 | 0.040 |
Why?
|
| Language Development Disorders | 1 | 2019 | 175 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2020 | 356 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 940 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2020 | 791 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2883 | 0.030 |
Why?
|
| Histone Deacetylase 1 | 1 | 2016 | 22 | 0.030 |
Why?
|
| Corneal Opacity | 1 | 2016 | 23 | 0.030 |
Why?
|
| Megalencephaly | 1 | 2016 | 58 | 0.030 |
Why?
|
| Coloboma | 1 | 2016 | 45 | 0.030 |
Why?
|
| Facies | 1 | 2016 | 156 | 0.030 |
Why?
|
| Protein Binding | 1 | 2020 | 1751 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 2016 | 179 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 2706 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2016 | 227 | 0.030 |
Why?
|
| Cell Line | 1 | 2020 | 2770 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 1461 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2016 | 677 | 0.030 |
Why?
|
| Cataract | 1 | 2016 | 221 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3753 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 647 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 4615 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2015 | 592 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 1272 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2143 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2820 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 3589 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 16294 | 0.020 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2005 | 3 | 0.020 |
Why?
|
| T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2005 | 9 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2005 | 9 | 0.020 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2005 | 13 | 0.020 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2005 | 38 | 0.020 |
Why?
|
| K562 Cells | 1 | 2005 | 95 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2005 | 40 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2005 | 809 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2005 | 348 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2005 | 381 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 551 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 1341 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 10274 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 543 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 3100 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 3882 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 12341 | 0.010 |
Why?
|